John Stuelpnagel
Chairman bei 10X GENOMICS, INC.
Vermögen: 92 Mio $ am 31.03.2024
Profil
John R. Stuelpnagel ist ein Unternehmer und Geschäftsmann, der Illumina, Inc., Fabric Genomics, Inc. und Ariosa Diagnostics, Inc. gegründet hat und der an der Spitze von 6 verschiedenen Unternehmen stand. Er ist Vorsitzender bei 10X Genomics, Inc. und bei Fabric Genomics, Inc. sowie Vorsitzender bei Inscripta, Inc. und Element Biosciences, Inc. John R. Stuelpnagel ist außerdem Mitglied des Vorstands von Federation Bio, Inc. und Encoded Therapeutics, Inc. In der Vergangenheit hatte Dr. Stuelpnagel die Position des Chief Operating Officer & Director bei Illumina, Inc. inne, war Associate bei CW Group, Inc. und BRD bei Sequenta, Inc. und Executive Chairman von Ariosa Diagnostics, Inc. Er erwarb einen Doktortitel und einen Bachelor-Abschluss an der University of California, Davis und einen MBA an der University of California, Los Angeles.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
10X GENOMICS, INC.
10,47% | 31.03.2023 | 2 105 736 ( 10,47% ) | 79 Mio $ | 31.03.2024 |
10X GENOMICS INC CLASS A
0,32% | 14.06.2023 | 335 601 ( 0,32% ) | 13 Mio $ | 31.03.2024 |
Aktive Positionen von John Stuelpnagel
| Unternehmen | Position | Beginn |
|---|---|---|
| 10X GENOMICS, INC. | Chairman | 01.08.2013 |
Fabric Genomics, Inc.
 Fabric Genomics, Inc. Packaged SoftwareTechnology Services Fabric Genomics, Inc. operates as an analytical genome interpretation company. It develops scalable and fully integrated informatics systems specifically design to interpret human genome sequences for research and clinical applications. The company was founded by by Martin G. Reese, Edward S. Kiruluta, John Stuelpnagel, and Paul Billings and is headquartered in Oakland, CA. | Founder | 01.08.2009 |
Inscripta, Inc.
 Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Chairman | 01.04.2017 |
Encoded Therapeutics, Inc.
 Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Director/Board Member | 01.05.2017 |
Element Biosciences, Inc.
 Element Biosciences, Inc. BiotechnologyHealth Technology Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company was founded by Molly He and is headquartered in San Diego, CA. | Chairman | 01.09.2017 |
Federation Bio, Inc.
 Federation Bio, Inc. BiotechnologyHealth Technology Federation Bio, Inc. uses microbiome therapeutics to address medical needs. The company was founded by Racquel N. Bracken, Michael Fischbach and Dylan Dodd and is headquartered in South San Francisco, CA. | Director/Board Member | 01.06.2020 |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Consultant / Advisor | 01.01.1998 |
Ehemalige bekannte Positionen von John Stuelpnagel
| Unternehmen | Position | Ende |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director/Board Member | 01.11.2017 |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA. | Founder | 01.01.2015 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von John Stuelpnagel
| University of California, Los Angeles | Masters Business Admin |
| University of California, Davis | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Finance |
Sequenta, Inc.
 Sequenta, Inc. BiotechnologyHealth Technology Sequenta, Inc. operates as a biotech company which discovers and develops clinical diagnostics based on immune system status. It develops molecular diagnostic assays based on a sequencing approach to the profiling of T and B cell receptor repertoires. The firm also provides sequencing-based test for minimal residual disease for leukemia and lymphoma. The company was founded by Thomas D. Willis and Malek Faham in 2007 and is headquartered in South San Francisco, CA. | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Finance |
Fabric Genomics, Inc.
Fabric Genomics, Inc. Packaged SoftwareTechnology Services Fabric Genomics, Inc. operates as an analytical genome interpretation company. It develops scalable and fully integrated informatics systems specifically design to interpret human genome sequences for research and clinical applications. The company was founded by by Martin G. Reese, Edward S. Kiruluta, John Stuelpnagel, and Paul Billings and is headquartered in Oakland, CA. | Technology Services |
Ariosa Diagnostics, Inc.
Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA. | Health Services |
Inscripta, Inc.
Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Commercial Services |
Federation Bio, Inc.
Federation Bio, Inc. BiotechnologyHealth Technology Federation Bio, Inc. uses microbiome therapeutics to address medical needs. The company was founded by Racquel N. Bracken, Michael Fischbach and Dylan Dodd and is headquartered in South San Francisco, CA. | Health Technology |
Element Biosciences, Inc.
Element Biosciences, Inc. BiotechnologyHealth Technology Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company was founded by Molly He and is headquartered in San Diego, CA. | Health Technology |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Commercial Services |
